Guided Therapeutics (GTHP) FCF Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41,234.00 |
| Sep 30, 2025 | -31,722.00 |
| Mar 31, 2024 | -61,667.00 |
| Jun 30, 2023 | 127,273.00 |
| Sep 30, 2022 | -1.30 Mn |
| Jun 30, 2022 | -346,000.00 |
| Mar 31, 2022 | -411,833.00 |
| Dec 31, 2021 | 417,412.00 |
| Sep 30, 2021 | 3.09 Mn |
| Dec 31, 2020 | -53,699.00 |
| Dec 31, 2019 | 2.15 Mn |
| Sep 30, 2019 | -400,000.00 |
| Jun 30, 2019 | -1.78 Mn |
| Mar 31, 2019 | -29,286.00 |
| Dec 31, 2018 | 2.01 Mn |
| Sep 30, 2018 | -1.78 Mn |
| Jun 30, 2018 | 685,000.00 |
| Mar 31, 2018 | -925,537.00 |
| Dec 31, 2017 | -144.00 |
| Sep 30, 2017 | -76,761.00 |
| Jun 30, 2017 | 208,752.00 |
| Mar 31, 2017 | -197,863.00 |
| Dec 31, 2015 | -4,167.00 |
| Sep 30, 2014 | 93,182.00 |
| Jun 30, 2014 | -102,440.00 |
| Mar 31, 2014 | -8,406.00 |
| Dec 31, 2013 | 7,463.00 |
| Mar 31, 2013 | -16,404.00 |
| Dec 31, 2012 | 12,448.00 |
| Sep 30, 2012 | 3,164.00 |
| Jun 30, 2012 | -7,067.00 |
| Mar 31, 2012 | -198.00 |
| Dec 31, 2011 | -234.00 |
| Sep 30, 2011 | 2,035.00 |
| Jun 30, 2011 | 0.00 |